Maria Valsecchi to Adolescent
This is a "connection" page, showing publications Maria Valsecchi has written about Adolescent.
Connection Strength
0.136
-
Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study. Vaccine. 2021 04 28; 39(18):2517-2525.
Score: 0.026
-
Effects of Lifestyle Modifications on Elevated Blood Pressure and Excess Weight in a Population of Italian Children and Adolescents. Am J Hypertens. 2018 09 11; 31(10):1147-1155.
Score: 0.022
-
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol. 2010 Nov 01; 28(31):4755-61.
Score: 0.012
-
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. Lancet Respir Med. 2020 08; 8(8):765-774.
Score: 0.006
-
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study. Eur J Cancer. 2019 11; 122:61-71.
Score: 0.006
-
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines. J Hypertens. 2019 06; 37(6):1213-1222.
Score: 0.006
-
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. Eur J Cancer. 2019 03; 110:86-97.
Score: 0.006
-
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study. Haematologica. 2019 09; 104(9):1812-1821.
Score: 0.006
-
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. Nat Med. 2019 02; 25(2):234-241.
Score: 0.006
-
Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study. Blood Press. 2018 12; 27(6):368-375.
Score: 0.005
-
Long-term survivors of childhood cancer: cure and care-the Erice Statement (2006) revised after 10 years (2016). J Cancer Surviv. 2018 10; 12(5):647-650.
Score: 0.005
-
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols. Br J Haematol. 2018 09; 182(5):705-711.
Score: 0.005
-
Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial. JAMA Neurol. 2018 01 01; 75(1):35-43.
Score: 0.005
-
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). J Clin Oncol. 2018 01 20; 36(3):244-253.
Score: 0.005
-
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. Blood. 2017 11 09; 130(19):2146-2149.
Score: 0.005
-
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia. Oncotarget. 2017 Jun 27; 8(26):42398-42413.
Score: 0.005
-
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia. J Clin Oncol. 2014 Nov 01; 32(31):3553-8.
Score: 0.004
-
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol. 2002 Sep; 118(3):741-7.
Score: 0.002